Taiwan FDA registration be00cfcff87ce02d32a57cd3c32893d7

Saibia Gel Urine Protein Electrophoresis Test Reagent (Unsterilized)

TW: 賽比亞 凝膠尿蛋白電泳檢測試劑 (未滅菌)
Taiwan flagTaiwan·Risk Class 1·SEBIA·Registered Jul 30, 2021 – Jul 30, 2026Expired
Registration details
Analysis ID
be00cfcff87ce02d32a57cd3c32893d7
Customs Code
DHA09402259003
Company information
Manufacturer
SEBIA
Manufacturer Country
France
Authorized Representative
ARQon Medtech Co., Ltd.
Product details
Intended Use
Limited to the first level identification range of the classification and grading management method of medical equipment, protein (chemical separation method) test system (A.1630).
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1630 Protein (Chemical Separation) Test System
Import Information
Input;; QMS/QSD
Dates and status
Registration Date
Jul 30, 2021
Expiry Date
Jul 30, 2026
Companies making similar products

Top companies providing products similar to "Saibia Gel Urine Protein Electrophoresis Test Reagent (Unsterilized)"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Saibia Gel Urine Protein Electrophoresis Test Reagent (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number be00cfcff87ce02d32a57cd3c32893d7 and manufactured by SEBIA. The authorized representative in Taiwan is ARQon Medtech Co., Ltd..

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including SEBIA, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations